Methods of using WISP antagonists

Details for Australian Patent Application No. 2004272066 (hide)

Owner Genentech, Inc.

Inventors Desnoyers, Luc

Agent Griffith Hack

Pub. Number AU-B-2004272066

PCT Pub. Number WO2005/025603

Priority 60/502,013 11.09.03 US

Filing date 11 September 2004

Wipo publication date 24 March 2005

Acceptance publication date 29 July 2010

International Classifications

C07K 14/475 (2006.01) Peptides having more than 20 amino acids

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 19/02 (2006.01) Drugs for skeletal disorders

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

9 March 2006 PCT application entered the National Phase

  PCT publication WO2005/025603 Priority application(s): WO2005/025603

29 July 2010 Application Accepted

  Published as AU-B-2004272066

5 August 2010 Corrigenda

  Applications Accepted - Name Index Under the name Genentech, Inc., Application No. 2004272066, under INID (22) correct the filing date to 9.09.04

25 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004272072-Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins

2004272062-Medical device for analyte monitoring and drug delivery